ATE502944T1 - 2-amino-5,7-dihydro-6h-pyrroloä3,4- düpyrimidinderivate als hsp-90-inhibitoren zur behandlung von krebs - Google Patents
2-amino-5,7-dihydro-6h-pyrroloä3,4- düpyrimidinderivate als hsp-90-inhibitoren zur behandlung von krebsInfo
- Publication number
- ATE502944T1 ATE502944T1 AT08702335T AT08702335T ATE502944T1 AT E502944 T1 ATE502944 T1 AT E502944T1 AT 08702335 T AT08702335 T AT 08702335T AT 08702335 T AT08702335 T AT 08702335T AT E502944 T1 ATE502944 T1 AT E502944T1
- Authority
- AT
- Austria
- Prior art keywords
- pyrroloä3
- düpyrimidene
- hsp
- dihydro
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88843307P | 2007-02-06 | 2007-02-06 | |
US2066108P | 2008-01-11 | 2008-01-11 | |
PCT/IB2008/000200 WO2008096218A1 (en) | 2007-02-06 | 2008-01-25 | 2-amin0-5, 7-dihydr0-6h- pyrrolo [3, 4-d] pyrimidine derivatives as hsp-90 inhibitors for treating cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE502944T1 true ATE502944T1 (de) | 2011-04-15 |
Family
ID=39367692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT08702335T ATE502944T1 (de) | 2007-02-06 | 2008-01-25 | 2-amino-5,7-dihydro-6h-pyrroloä3,4- düpyrimidinderivate als hsp-90-inhibitoren zur behandlung von krebs |
Country Status (22)
Country | Link |
---|---|
US (1) | US20100093696A1 (de) |
EP (1) | EP2118111B1 (de) |
JP (1) | JP4523073B2 (de) |
KR (1) | KR20090116789A (de) |
AP (1) | AP2009004954A0 (de) |
AT (1) | ATE502944T1 (de) |
AU (1) | AU2008212645A1 (de) |
BR (1) | BRPI0807165A2 (de) |
CA (1) | CA2677365A1 (de) |
CO (1) | CO6220971A2 (de) |
CR (1) | CR10963A (de) |
CU (1) | CU20090141A7 (de) |
DE (1) | DE602008005715D1 (de) |
DO (1) | DOP2009000200A (de) |
EA (1) | EA200970669A1 (de) |
EC (1) | ECSP099565A (de) |
IL (1) | IL200169A0 (de) |
MA (1) | MA31170B1 (de) |
MX (1) | MX2009008386A (de) |
NI (1) | NI200900155A (de) |
TN (1) | TN2009000329A1 (de) |
WO (1) | WO2008096218A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2331544A1 (de) * | 2008-08-13 | 2011-06-15 | Pfizer Inc. | 2-aminopyrimidinverbindungen als wirksame hsp-90-inhibitoren |
GB0907284D0 (en) | 2009-04-28 | 2009-06-10 | Queen Mary & Westfield College | Compounds for inducing cellular apoptosis |
AR077405A1 (es) | 2009-07-10 | 2011-08-24 | Sanofi Aventis | Derivados del indol inhibidores de hsp90, composiciones que los contienen y utilizacion de los mismos para el tratamiento del cancer |
FR2949467B1 (fr) | 2009-09-03 | 2011-11-25 | Sanofi Aventis | Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation |
WO2011082268A2 (en) | 2009-12-30 | 2011-07-07 | Arqule Inc. | Substituted naphthalenyl-pyrimidine compounds |
EP2752201A1 (de) * | 2013-01-04 | 2014-07-09 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | C-terminale HSP90-Hemmer zur Behandlung von Hypophysenadenomen |
CA2903431C (en) | 2013-03-14 | 2022-12-06 | Kalyra Pharmaceuticals, Inc. | Bicyclopentane analgesic compounds |
CN108947867A (zh) | 2013-12-12 | 2018-12-07 | 卡利拉制药公司 | 双环烷基化合物及合成 |
CN113336653A (zh) | 2014-03-07 | 2021-09-03 | 里科瑞尔姆Ip控股有限责任公司 | 螺桨烷衍生物及合成 |
US10336768B2 (en) * | 2014-06-13 | 2019-07-02 | Yuma Therapeutics, Inc. | Pyrimidine compounds and methods using the same |
US10308609B2 (en) | 2014-09-17 | 2019-06-04 | Zeno Royalties & Milestones, LLC | Bicyclic compounds |
US10227029B2 (en) * | 2015-08-07 | 2019-03-12 | Kawasaki Jukogyo Kabushiki Kaisha | Container holder attached to utility vehicle |
MX2019013557A (es) | 2017-05-15 | 2022-01-27 | Recurium Ip Holdings Llc | Compuestos biciclo[1.1.1]pentilo sustituidos y uso de los mismos para el tratamiento del dolor y fiebre. |
WO2020243457A1 (en) * | 2019-05-29 | 2020-12-03 | Viogen Biosciences, Llc | Compounds and therapeutic uses thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9711643D0 (en) | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
AR034118A1 (es) | 2000-02-15 | 2004-02-04 | Sugen Inc | Compuestos de 2-indolinonas sustituidas con pirroles inhibidoras de proteinquinasas; sus composiciones farmaceuticas e intermediarios de sintesis |
CA2473510A1 (en) * | 2002-01-23 | 2003-07-31 | Bayer Pharmaceuticals Corporation | Pyrimidine derivatives as rho-kinase inhibitors |
US7312330B2 (en) * | 2003-12-24 | 2007-12-25 | Renovis, Inc. | Bicycloheteroarylamine compounds as ion channel ligands and uses thereof |
CA2602257A1 (en) * | 2005-03-30 | 2006-10-05 | Conforma Therapeutics Corporation | Alkynyl pyrrolopyrimidines and related analogs as hsp90-inhibitors |
-
2008
- 2008-01-25 MX MX2009008386A patent/MX2009008386A/es unknown
- 2008-01-25 KR KR1020097018581A patent/KR20090116789A/ko not_active Application Discontinuation
- 2008-01-25 DE DE602008005715T patent/DE602008005715D1/de active Active
- 2008-01-25 AU AU2008212645A patent/AU2008212645A1/en not_active Abandoned
- 2008-01-25 AP AP2009004954A patent/AP2009004954A0/xx unknown
- 2008-01-25 EP EP08702335A patent/EP2118111B1/de active Active
- 2008-01-25 EA EA200970669A patent/EA200970669A1/ru unknown
- 2008-01-25 US US12/524,892 patent/US20100093696A1/en not_active Abandoned
- 2008-01-25 JP JP2009548758A patent/JP4523073B2/ja not_active Expired - Fee Related
- 2008-01-25 CU CU20090141A patent/CU20090141A7/es unknown
- 2008-01-25 BR BRPI0807165-9A patent/BRPI0807165A2/pt not_active IP Right Cessation
- 2008-01-25 WO PCT/IB2008/000200 patent/WO2008096218A1/en active Application Filing
- 2008-01-25 AT AT08702335T patent/ATE502944T1/de not_active IP Right Cessation
- 2008-01-25 CA CA002677365A patent/CA2677365A1/en not_active Abandoned
-
2009
- 2009-07-30 IL IL200169A patent/IL200169A0/en unknown
- 2009-08-04 TN TNP2009000329A patent/TN2009000329A1/fr unknown
- 2009-08-04 CR CR10963A patent/CR10963A/es unknown
- 2009-08-04 CO CO09081255A patent/CO6220971A2/es not_active Application Discontinuation
- 2009-08-05 NI NI200900155A patent/NI200900155A/es unknown
- 2009-08-06 MA MA32149A patent/MA31170B1/fr unknown
- 2009-08-06 DO DO2009000200A patent/DOP2009000200A/es unknown
- 2009-08-06 EC EC2009009565A patent/ECSP099565A/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP4523073B2 (ja) | 2010-08-11 |
AP2009004954A0 (en) | 2009-08-31 |
US20100093696A1 (en) | 2010-04-15 |
MA31170B1 (fr) | 2010-02-01 |
NI200900155A (es) | 2010-06-30 |
CU20090141A7 (es) | 2011-04-26 |
CO6220971A2 (es) | 2010-11-19 |
CR10963A (es) | 2009-08-27 |
WO2008096218A1 (en) | 2008-08-14 |
IL200169A0 (en) | 2010-04-15 |
EP2118111B1 (de) | 2011-03-23 |
KR20090116789A (ko) | 2009-11-11 |
EP2118111A1 (de) | 2009-11-18 |
ECSP099565A (es) | 2009-09-29 |
CA2677365A1 (en) | 2008-08-14 |
EA200970669A1 (ru) | 2010-02-26 |
TN2009000329A1 (fr) | 2010-12-31 |
AU2008212645A1 (en) | 2008-08-14 |
BRPI0807165A2 (pt) | 2014-05-06 |
DE602008005715D1 (de) | 2011-05-05 |
DOP2009000200A (es) | 2009-09-15 |
JP2010518066A (ja) | 2010-05-27 |
MX2009008386A (es) | 2009-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE502944T1 (de) | 2-amino-5,7-dihydro-6h-pyrroloä3,4- düpyrimidinderivate als hsp-90-inhibitoren zur behandlung von krebs | |
DK3289876T3 (da) | Forbindelser til behandling af cancer | |
DK2195015T3 (da) | Sammensætning til behandling af prostatacancer | |
BRPI0812293A2 (pt) | Derivados de 2-oxo-3-benzilbenzoxazol-2 -ona e compostos relacionados como inibidores de met quinase para o tratamento de tumores | |
ATE527241T1 (de) | Pyridiazinonderivate zur behandlung von tumoren | |
SMAP200900085A (it) | 3-imidazolil-indoli per il trattamento di malattieproliferative | |
DK2426106T3 (da) | Piperidin- og piperazinderivat til behandling af tumorer | |
DK2478907T3 (da) | Sammensætninger til behandling af kræft | |
DK2504005T3 (da) | Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme | |
BRPI0810206A2 (pt) | Método de tratar câncer | |
DK3456707T3 (da) | 4-(p-quinonyl)-2-hydroxybutanamidderivater til behandling af mitokondriesygdomme | |
ATE550329T1 (de) | Heterobicyclische sulfonamidderivate zur behandlung von diabetes | |
EA201171367A1 (ru) | Винилиндазолильные соединения | |
BRPI0820544A2 (pt) | 4-pirazolil-n-arilpirimidin-2-aminas e pirazolil-n-heteroarilpirimidin-2-aminas como inibidores de janus cinase | |
BRPI0921321A2 (pt) | métodos para o tratamento de indwcções e tumores | |
EA200900798A1 (ru) | Производные индол-4-илпиримидинил-2-иламина и их применение в качестве ингибиторов циклинзависимой киназы | |
DK2121139T3 (da) | Formulations for cancer treatment | |
SE0702104L (sv) | Förfarande för behandling av avfall | |
BRPI0912683A2 (pt) | tratamento de tumores metastáticos | |
ATE532507T1 (de) | Neramexane zur behandlung von subakuten tinnitus | |
DK2452189T3 (da) | Fremgangsmåde til identifikation af forbindelser til behandling af cancer | |
FI20085275A0 (fi) | Menetelmä biomassan käsittelemiseksi | |
BRPI0908635A2 (pt) | composto, composição farmacêutica e método de tratamento de câncer | |
BRPI0811517A2 (pt) | Compostos e composições como inibidores de c-kit e pdgfr cinase. | |
BRPI1007995A2 (pt) | orto-aminoamidas para o tratamento de cãncer. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |